Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients
Condition(s):SchizophreniaLast Updated:February 15, 2019Recruiting
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:February 15, 2019Recruiting
Condition(s):SchizophreniaLast Updated:December 29, 2020Completed
Condition(s):Schizophrenia; Bipolar I DisorderLast Updated:September 2, 2020Completed
Condition(s):Schizophrenia; Antipsychotics; Long-Acting Injection; LAI; AripiprazoleLast Updated:September 16, 2020Recruiting
Condition(s):Schizophrenia; Major Depressive Disorder; Bi-Polar Disorder; Schizo Affective DisorderLast Updated:June 18, 2020Active, not recruiting
Condition(s):SchizophreniaLast Updated:March 6, 2019Completed
Condition(s):SchizophreniaLast Updated:December 29, 2020Completed
Condition(s):Autistic DisorderLast Updated:December 29, 2020Completed
Condition(s):Tourette SyndromeLast Updated:December 29, 2020Completed
Condition(s):SchizophreniaLast Updated:March 24, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.